A 26-week randomised, controlled, open label, multicentre, multinational, treat to target trial investigating the impact of dietary intervention on weight change and the relationship between weight change and baseline body mass index (BMI) in subjects with type 2 diabetes inadequately controlled on oral antidiabetic drugs (OADs) initiating insulin therapy with insulin detemir in combination with metformin.
Phase of Trial: Phase IV
Latest Information Update: 03 May 2017
At a glance
- Drugs Insulin detemir (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DIET
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 17 Apr 2012 Actual end date changed from 15 Aug 2011 to 14 Nov 2011 as reported by European Clinical Trials Database record.
- 17 Apr 2012 Additional location (Germany) added as reported by European Clinical Trials Database record.